��������

David Carner has over 30 years of experience in the medical device industry. David began their career in 1989 as a Project Engineer, Mechanical Design and Development at Intermedics. In 1994, they joined St. Jude Medical - Pacesetter Inc. as a Senior Development Engineer, where they were responsible for the design and development of the TENDRIL SDX thin bipolar active fixation implantable heart pacing lead. In 1997, they moved to Cardima as Director of Product Development, where they were responsible for the direction of the R&D group with regards to development of electrophysiological micro-catheters used for mapping and ablation of Atrial Fibrillation/Flutter and Ventricular Tachycardia. In 2000, they joined Guidant as Director of Quality and Director of R&D. In the same year, they also joined Guidant/Abbott Vascular Devices as Director of Quality, where they were part of the management team responsible for a successful launch of the first carotid stent and embolic protection system approved in the U.S. In 2008, they joined PhotoThera as Vice President Quality Assurance, where they were a member of the executive management team. In 2009, they moved to Broncus Technologies as Vice President Quality Assurance, and in 2010 they joined Dexcom as Vice President Quality Assurance. In 2016, they joined BAROnova as Vice President Quality Assurance, where they implemented a Quality infrastructure and processes compliant to FDA and ISO13485:2016 requirements. David currently serves as Vice President Quality at Biolinq.

David Carner attended The University of Texas at Arlington from 1984 to 1988, where they earned a Bachelor of Science in Aerospace Engineering (BSAE).